Variceal rebleeding occurred during follow-up in 12 ( 36.4 % ) and 11 ( 35.5 % ) patients in the carvedilol and VBL groups , respectively ( p = 0.857 ) , with 9 ( 27.3 % ) and 16 ( 51.6 % ) deaths in each group , respectively ( p = 0.110 ) .